Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart
- 9 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (2) , 273-279
- https://doi.org/10.1161/01.cir.0000021120.90970.b9
Abstract
Background — Endogenous nitric oxide (NO) has been reported to inhibit oxygen consumption in the normal heart, so that nonselective inhibition of NO synthase (NOS) caused an increase of myocardial oxygen consumption (MV̇O 2 ). Although endothelial NOS responses are depressed in congestive heart failure (CHF), inducible NOS (iNOS) may be expressed in failing myocardium. Methods and Results — This study tested the hypothesis that NOS inhibition would increase MV̇O 2 in the failing heart. CHF was produced in dogs by use of the rapid ventricular pacing model. In comparison with normal values, animals with CHF had reduced coronary blood flow and MV̇O 2 at rest, with a blunted response to treadmill exercise. Selective iNOS inhibition with S -methylisothiourea (1.5 mg/kg IC) increased left ventricular systolic pressure and left ventricular dP/dt and caused an increase in MV̇O 2 at rest and during exercise ( P 2 and rate-pressure product. In contrast, S -methylisothiourea had no effect on MV̇O 2 or coronary flow in normal animals, although nonselective NOS inhibition with N G -nitro- l -arginine did cause an increase of MV̇O 2 in normal and in CHF animals. Conclusions — The results indicate that endogenous NO can modulate MV̇O 2 in failing hearts, but unlike the normal heart, this NO appears to be produced, at least in part, by iNOS.Keywords
This publication has 14 references indexed in Scilit:
- Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxidePublished by Wiley ,2001
- Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytesJournal of the American College of Cardiology, 2000
- Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human heartsThe American Journal of Cardiology, 1999
- Aorta and Skeletal Muscle NO Synthase Expression in Experimental Heart FailureJournal of Molecular and Cellular Cardiology, 1996
- Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathyThe Lancet, 1996
- Nitrovasodilators ITF 296 and Isosorbide Dinitrate Exert Antiischemic Activity by Dilating Coronary Penetrating ArteriesJournal of Cardiovascular Pharmacology, 1995
- Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dogCardiovascular Research, 1994
- Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failureCardiovascular Research, 1991
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990